Pharma News, 2018

(Reuters) - AstraZeneca Plc’s immunotherapy treatment Imfinzi did not meet the main goals in a late-stage study for advanced head and neck cancer, the London-listed drugmaker said on Friday.

Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could not take hormone replacement, including breast cancer survivors, according to results of a trial ...

Basel, December 3, 2018 - Novartis today announced that the U.

If you've got plans to spend the entire weekend sat down scoffing food, there is no reason to feel guilty - as long as you exercise on the Friday.

Johnson & Johnson's Janssen has entered into an agreement potentially worth up to $1.

The government has published the second Life Sciences Sector Deal, detailing both public and private sector investments into the sector, including a £1 billion investment in UK research and developme...

Shareholders at Japanese drug giant Takeda on Wednesday approved a plan to buy Irish pharmaceuticals firm Shire in a deal worth around $60 billion, the biggest foreign takeover ever by a Japanese firm...

BEDFORD, Mass.

SOUTH SAN FRANCISCO, Calif.

The human brain is rich in lipids.

Preclinical experiments by University of Alabama at Birmingham researchers suggest the cancer drugs vorinostat, belinostat and panobinostat might be repurposed to treat infections caused by human papi...

Bayer announced today that the U.